To evaluate the effect of high doses EPA/DHA for patients with cystoid macular oedema.Methods
14 eyes with cystoid macular oedema (8 secondary to chronic inflammation and 6 secondary to branch retinal vein occlusion) were treated with 5g/day of EPA/DHA. Visual acuity and macular oedema results from OCT scans were noted.Results
The mean macular oedema was reduced from 564um to 243um in 12 months. The mean visual acuity gain at 12 months was 2.85 lines. No anti-VEGF injections were given during treatment with high doses EPA/DHA.Conclusion
Innovative therapy of using high doses of fatty acids to reduce macular oedema and improve vision in patients with cystoid macular oedema secondary to inflammation or branch retinal vein occlusion.